Experiments on a new phosphine-peptide chelator for labelling of peptides with Tc-99m

Nuclear Medicine and Biology

Volumn 26, Issue 3, 1999, Pages 251-258

  Santimaria, M ^a,b   Blok, D ^a   Feitsma, R I J ^a   Mazzi, U ^b   Pauwels, E K J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Peptides; Phosphine ligands; PNNS coordination; Technetium 99m labelling

Indexed keywords

CHELATING AGENT; CHOLECYSTOKININ; PHOSPHINE DERIVATIVE; TECHNETIUM 99M; TETRAGASTRIN;

ARTICLE; CHELATION; CHEMICAL REACTION; CHEMICAL STRUCTURE; COMPLEX FORMATION; CONJUGATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; PH; REACTION ANALYSIS; REACTION TIME;

CHELATING AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ISOTOPE LABELING; ORGANOTECHNETIUM COMPOUNDS; PEPTIDES; PHOSPHINES; RADIOPHARMACEUTICALS; TECHNETIUM; TETRAGASTRIN;

EID: 0033119753     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(98)00106-1     Document Type: Article

References (23)

1. Blok D., Maina T., Feitsma H., Boldrin F., Giacon M., Santimaria M., Pauwels E., Mazzi U. Labelling of (3-diphenylphosphine) propionylglycyl-L-(S-benzyl)cysteinyl methyl ester with 99mTc Radiochemical characterization of the 99mTc-complex . Nicolini M., Bandoli G., Mazzi U. Technetium and Rhenium in Chemistry and Nuclear Medicine 4. 1995;343-347 S.G. Editorial, Padua, Italy.
2. Bormans G., Cleynhens B., Adriaens P., Vanbilloen H., De Roo M., Verbruggen A. Investigation of the labelling characteristics of 99mTc-mercaptoacetyltriglycine. Nucl. Med. Biol. 22:1995;339-349.
3. Bormans G., Cleynhens B., Perdieus D., de Roo M., Verbruggen A. Comparison of benzyl, benzoyl and benzamidomethyl as protective groups for mercaptoacetyltriglycine (MAG3). J. Labelled Compd. Radiopharm. 26:1989;50-52.
4. Eckelman W.C. Developments of radiochemically pure antibodies. Cancer Res. 50:1990;780s-782s.
5. Eckelman W.C. Radiolabelling with technetium-99m to study high-capacity and low-capacity biochemical systems. Eur. J. Nucl. Med. 22:1995;249-263.
6. Emson P.C., Sandberg B.E.B. Cholecystokinin and substance P in the central nervous system. Ann. Rep. Med. Chem. 18:1983;31-39.
7. Fischman A.J., Babich J.W., Rubin R.H. Infection imaging with technetium-99m-labeled chemotactic peptide analogs. Semin. Nucl. Med. 24:1994;154-168.
8. Fischman A.J., Pike M.C., Kroon D., Fucello A.J., Rexinger D., tenKate C., Wilkinson R., Rubin R.H., Strauss H.W. Imaging focal sites of bacterial infection in rats with indium-111-labeled chemotactic peptide analogs. J. Nucl. Med. 32:1991;483-491.
9. Fritzberg A.R. Advances in 99mTc-labeling of antibodies. Nuklearmedizin. 26:1987;7-12.
10. Haradahira T., Suzuki K., Inoue O. Synthesis of (R)- and (S)-[C-11]L-365,260 for PET studies of brain cholecystokinin (CCK) receptors. [abstract # 1016] J. Nucl. Med. 35:1994;248P.
11. Leveille J., Demonceau G., De Roo M., Rigo P., Taillefer R., Morgan R.A., Kupranick D., Walovitch R.C. Characterization of 99mTc-L,L-ECD for brain perfusion imaging, Part 2 Biodistribution and brain imaging in humans . J. Nucl. Med. 30:1989;1902-1910.
12. Liu S., Edwards D.S., Barrett J.A. Tc 99m labeling of highly potent small peptides. Bioconjugate Chem. 8:1997;621-636.
13. Maina T., Stolz B., Albert R., Nock B., Bruns C., Mäcke H. Synthesis, radiochemical and biological evaluation of 99mTc[N4-(D)PHE]-octreotide, a new octreotide derivative with high affinity for somatostatin receptors. Nicolini M., Bandoli G., Mazzi U. Technetium and Rhenium in Chemistry and Nuclear Medicine 4. 1995;395-400 S.G. Editorial, Padua, Italy.
14. Mazzi U., Nicolini M., Bandoli G., Refosco F., Tisato F., Moresco A., Duatti A. Technetium coordination chemistry Development of new backbones for 99mTc radiopharmaceuticals . Nicolini M., Bandoli G., Mazzi U. Technetium and Rhenium in Chemistry and Nuclear Medicine 3. 1989;39-50 Cortina International, Verona, Italy.
15. McAfee J.G., Neumann R.D. Radiolabeled peptides and other ligands for receptors overexpressed in tumor cells for imaging neoplasms. Nucl. Med. Biol. 23:1996;673-676.
16. Rao T.N., Adhikesavalu D., Camerman A., Fritzberg A.R. Technetium(V) and rhenium(V) complexes of 2,3-Bis(mercaptoacetamido)propanoate. Chelate ring stereochemistry and influence on chemical and biological properties. J. Am. Chem. Soc. 112:1990;5798-5804.
17. 99mTc. Nucl. Med. Biol. 18:1991;667-676.
18. Santimaria M., Maina T., Mazzi U., Nicolini M. Preparation and characterization of a new rhenium(V) complex containing the 3-diphenylphosphinopropionylglycyl L (S benzyl)cysteinyl methyl ester ligand. Inorg. Chim. Acta. 240:1995;291-297.
19. Santimaria M., Mazzi U., Gatto S., Dolmella A., Bandoli G., Nicolini M. Rhenium complexes with phosphine containing peptides Synthesis and characterization of oxorhenium(V) complexes with N(N [3(diphenylphosphino)propionyl]glycyl)-L-S-benzylcysteine and its methyl ester . J. Chem. Soc. Dalton Trans. 21:1997;1765-1771.
20. Santimaria M., Uccelli L., Duatti A., Mazzi U., Giganti and Piffanelli A. (1996) A new chelating system for labeling small peptides with technetium-99m and rhenium-188. Eur. J. Nucl. Med. 23, 1141.
21. Thakur M.L. Immunoscintigraphic imaging of inflammatory lesions Preliminary findings and future possibilities . Semin. Nucl. Med. 20:1990;92-98.
22. Verbruggen A.M. Radiopharmaceuticals State of the art . Eur. J. Nucl. Med. 17:1990;346-364.
23. Viadyanathan G., Zalutsky M.R. Fluorine-18 labeled chemotactic peptides A potential for the PET imaging of bacterial infection . Nucl. Med. Biol. 22:1995;759-764.